Treosulfan
Orphan DrugFDA Approved (2025)
Contents
Description
An alkylating agent used with fludarabine as conditioning before allogeneic hematopoietic stem cell transplantation in AML or MDS. FDA-approved January 2025.
Indications & Therapeutic Use
Conditioning for allogeneic HSCT (AML/MDS)
Global Availability (1 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| Standard Marketing Authorization | — | — | Approved |
Buy / Source Treosulfan — GNH India
26 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Ovastat
EU
Trecondi
EU
TRECONDYV
5 GpowderCANADA
Treoall
5gmvialsIndia
Treossulfano Tillomed
EU
Treosulfan Medac
EU
Treosulfan Tillomed
EU
Treosulfan Tillomed Laboratories
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Treosulfan
| Generic Name | treosulfan |
| Brands | 1 brand available |
| Active Ingredient | treosulfan |
| Drug Class | Conditioning for allogeneic HSCT (AML/MDS) |
| Manufacturer | medac |
| Medical Code | L01AB02 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Reg. Status | FDA Approved (2025) |
| Countries | 1 countries |
Authority Signals
Last Verified7/24/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations2 Validated Nodes